Verapamil Effect in Cystic Fibrosis-related Dysglycemia

Clinical trial NCT07688070 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07688070
Sponsor: Rhode Island Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis Related Diabetes Cystic Fibrosis (CF)Abnormal Glucose Tolerance

Start date: 2026-08-01
Primary completion: 2028-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.